Comerica Bank Biomarin Pharmaceutical Inc Transaction History

Comerica Bank

  • $24.4 Billion
  • Q4 2024

A detailed history of Comerica Bank transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Comerica Bank holds 61,511 shares of BMRN stock, worth $3.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
61,511
Previous 65,227 5.7%
Holding current value
$3.99 Million
Previous $4.58 Million 11.8%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$61.93 - $70.49 $230,131 - $261,940
-3,716 Reduced 5.7%
61,511 $4.04 Million
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $551,538 - $749,875
-7,991 Reduced 10.91%
65,227 $4.58 Million
Q2 2024

Aug 15, 2024
BUY
$74.43 - $92.22 $4.92 Million - $6.1 Million
66,161 Added 937.52%
73,218 $6.03 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $24,807 - $29,304
-296 Reduced 4.03%
7,057 $616,000
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $155,260 - $200,664
2,037 Added 38.32%
7,353 $708,000
Q3 2023

Nov 21, 2023
SELL
$85.07 - $94.48 $2.5 Million - $2.77 Million
-29,334 Reduced 84.66%
5,316 $470,000
Q2 2023

Aug 22, 2023
BUY
$86.68 - $100.3 $2.73 Million - $3.16 Million
31,528 Added 1009.87%
34,650 $63,000
Q4 2022

Jan 26, 2023
BUY
$80.93 - $108.63 $24,683 - $33,132
305 Added 10.83%
3,122 $0
Q3 2022

Oct 28, 2022
BUY
$82.16 - $96.94 $30,481 - $35,964
371 Added 15.17%
2,817 $253,000
Q2 2022

Aug 02, 2022
SELL
$71.48 - $86.85 $233,096 - $283,217
-3,261 Reduced 57.14%
2,446 $211,000
Q1 2022

Apr 27, 2022
SELL
$74.28 - $92.69 $388,113 - $484,305
-5,225 Reduced 47.8%
5,707 $440,000
Q4 2021

Feb 18, 2022
SELL
$71.72 - $91.47 $645,336 - $823,047
-8,998 Reduced 45.15%
10,932 $965,000
Q3 2021

Nov 22, 2021
SELL
$74.77 - $85.47 $347,381 - $397,093
-4,646 Reduced 18.9%
19,930 $1.54 Million
Q2 2021

Aug 26, 2021
SELL
$75.51 - $84.79 $138,409 - $155,420
-1,833 Reduced 6.94%
24,576 $2.05 Million
Q1 2021

Apr 28, 2021
SELL
$74.73 - $90.69 $43,941 - $53,325
-588 Reduced 2.18%
26,409 $1.99 Million
Q4 2020

Jan 28, 2021
BUY
$72.61 - $90.2 $206,067 - $255,987
2,838 Added 11.75%
26,997 $2.37 Million
Q3 2020

Oct 30, 2020
SELL
$71.87 - $131.03 $13,799 - $25,157
-192 Reduced 0.79%
24,159 $1.84 Million
Q2 2020

Jul 31, 2020
SELL
$79.55 - $124.22 $1,193 - $1,863
-15 Reduced 0.06%
24,351 $3 Million
Q1 2020

May 01, 2020
BUY
$71.37 - $96.85 $724,120 - $982,640
10,146 Added 71.35%
24,366 $2.06 Million
Q4 2019

Feb 07, 2020
BUY
$64.27 - $86.37 $44,603 - $59,940
694 Added 5.13%
14,220 $1.2 Million
Q3 2019

Oct 31, 2019
BUY
$67.4 - $85.11 $3,707 - $4,681
55 Added 0.41%
13,526 $911,000
Q2 2019

Aug 02, 2019
BUY
$80.35 - $93.9 $64,038 - $74,838
797 Added 6.29%
13,471 $0
Q1 2019

May 02, 2019
BUY
$84.2 - $98.62 $220,098 - $257,792
2,614 Added 25.98%
12,674 $0
Q4 2018

Feb 06, 2019
SELL
$80.14 - $106.07 $2,885 - $3,818
-36 Reduced 0.36%
10,060 $948,000
Q3 2018

Nov 01, 2018
BUY
$93.92 - $105.72 $53,064 - $59,731
565 Added 5.93%
10,096 $1.01 Million
Q2 2018

Aug 01, 2018
BUY
$76.01 - $99.03 $189,188 - $246,485
2,489 Added 35.35%
9,531 $991,000
Q1 2018

May 01, 2018
SELL
$77.67 - $92.63 $11,029 - $13,153
-142 Reduced 1.98%
7,042 $589,000
Q4 2017

Feb 02, 2018
SELL
$80.76 - $95.13 $11,064 - $13,032
-137 Reduced 1.87%
7,184 $656,000
Q3 2017

Nov 06, 2017
BUY
$80.6 - $94.95 $590,072 - $695,128
7,321
7,321 $600,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
183M
Call Options Held
2.07M
Put Options Held
1.72M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email